Agilis’ gene therapy program has been developed in collaboration with National Taiwan University and the U.S. National Institutes of Health’s National Center for Advancing ...

Agilis has licensed its AADC deficiency gene therapy program from National Taiwan University (NTU) based on research by Paul Wuh-Liang Hwu, M.D., Ph.D., at NTU Hospital, where 18 patients have ...

Agilis Biotherapeutics, LLC (Agilis), ... Phase II Program for Rare CNS Disease Expands Agilis’ Pipeline. January 28, 2016 07:30 AM Eastern Standard Time. CAMBRIDGE, Mass.-- ...